We scoured the nation to identify the best stock in every state. Monsanto (symbol MON) is the publicly traded company we picked in Missouri. The company headquarters is located in St. Louis.
A word of caution: Since we selected a single stock from each state (plus one from D.C), and choices in some states are sparse, a few of our picks are best suited to investors comfortable with a higher degree of risk. This is not necessarily one of our 51 favorite stocks in the entire U.S., in other words.
Monsanto by the Numbers
- Headquarters: St. Louis
- Share price: $116.84
- Market value: $51.2 billion
- Price-earnings ratio: 25
(Prices and data are as of June 22, 2017)
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
One apparent fan of a proposed merger between German drug and pesticide manufacturer Bayer and seed giant Monsanto: Warren Buffett. Berkshire Hathaway disclosed in February that it bought 8 million shares of Monsanto during the fourth quarter of 2016, after the merger announcement in September. Should the deal meet regulatory approval, Bayer will acquire Monsanto for $128 a share in an all-cash transaction. Morningstar analysts say there’s an 80% chance the deal will close by the end of the year, given the lack of broad overlap between the two companies and, therefore, few antitrust arguments against the merger. The regulatory go-ahead would mean a merger arbitrage opportunity for holders of Monsanto stock, which trades at a 9.4% discount to Bayer’s offer price. Should regulators kill the merger, Bayer has agreed to pay Monsanto $2 billion as a “break-up fee.”
Either way, says CFRA analyst Christopher Muir, Monsanto is a leading innovator in genetically modified produce, and an increasing share of crops worldwide reflect Monsanto’s mark. The company’s dominant market position should allow it to command higher prices, which Muir believes will drive above-average long-term earnings growth. His 12-month price target for the stock matches Bayer’s offer price at $128.
-
How to Turn Your Retirement Dreams into Reality (Despite Your Fears)Stressing over shrinking savings, rising healthcare costs, or losing your purpose can give you chills, but smart money moves can lead to financial freedom and a happy retirement.
-
Figma IPO: Should You Buy FIG Stock?The Figma IPO has plenty of buzz building around it, with the design software company expected to start trading next week.
-
If You'd Put $1,000 Into Berkshire Hathaway Stock 20 Years Ago, Here's What You'd Have TodayBerkshire Hathaway is a long-time market beater, but the easy money in BRK.B has already been made.
-
If You'd Put $1,000 Into Procter & Gamble Stock 20 Years Ago, Here's What You'd Have TodayProcter & Gamble stock is a dependable dividend grower, but a disappointing long-term holding.
-
My Three-Day Rule for Investing: And If it Applies NowStock Market I've seen a lot in my career. Here's what I see now in the stock market.
-
Is It Time to Invest in Europe?Stock Market Europe is being shaken out of its lethargy, militarily and otherwise, by Donald Trump's changes in U.S. policy. Should investors start buying?
-
Why Is Warren Buffett Selling So Much Stock?Berkshire Hathaway is dumping equities, hoarding cash and making market participants nervous.
-
If You'd Put $1,000 Into Google Stock 20 Years Ago, Here's What You'd Have TodayGoogle parent Alphabet has been a market-beating machine for ages.
-
Stock Market Today: Stocks Retreat Ahead of Nvidia EarningsMarkets lost ground on light volume Wednesday as traders keyed on AI bellwether Nvidia earnings after the close.
-
Stock Market Today: Stocks Edge Higher With Nvidia Earnings in FocusNvidia stock gained ground ahead of tomorrow's after-the-close earnings event, while Super Micro Computer got hit by a short seller report.
